Figure 1.

Positron emission tomography scans. (A) Before treatment with lenalidomide; (B) after 4 months of continuous lenalidomide treatment; and (C) after 15 months of continuous lenalidomide treatment.

Mandac and Kolonic Journal of Hematology & Oncology 2010 3:20   doi:10.1186/1756-8722-3-20
Download authors' original image